LumaCyte
PrivateLast Round
Series B
Sep 6, 2023
Total Funding Raised
$12.67M
Company Overview
LumaCyte is a bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation for research and biomanufacturing applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LumaCyte Comparables
Compare LumaCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ThinkCyte | 86% | |
| LevitasBio | 83% | |
| NanoCellect Biomedical | 83% |
LumaCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 6, 2023 | ||||
| Series A | Mar 2, 2022 | ||||
| Grant | Aug 30, 2019 | ||||
| Grant | Jan 9, 2019 | ||||
| Grant | Apr 1, 2018 |
Key People
Founding team and executive leadership
LumaCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Carnegie Mellon University Investment Office | Grant |
| Genentech | Grant |
| Rensselaer Polytechnic Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Grew 20% QoQ, from 20 to 24 employees.
- Nov 27, 2023
Grew 20% QoQ, from 20 to 24 employees.
LumaCyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LumaCyte's valuation, stock price, and market status.
Is LumaCyte a public or private company?
LumaCyte is a private company.
What is the current stock price of LumaCyte?
LumaCyte is a private company with no public stock price. No recent secondary market data is available.
How much is LumaCyte worth (valuation)?
Valuation information for LumaCyte is not publicly available.
Can I buy LumaCyte stock?
LumaCyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was LumaCyte's last funding round?
LumaCyte's most recent funding round was Series B on September 6, 2023.
Who are the main investors in LumaCyte?
Key investors in LumaCyte include Carnegie Mellon University, Genentech, Rensselaer Polytechnic Institute.
Will LumaCyte IPO soon?
No public IPO plans have been announced for LumaCyte.
How can I track LumaCyte secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LumaCyte's secondary market activity and sign up for updates.